163 related articles for article (PubMed ID: 19721171)
1. [Prostatic specific antigen (PS), pro-inflammatory cytokines, and prostatic pathology (benign prostatic hyperplasia and cancer). Relationship with malignancy].
Cansino Alcaide JR; Vera San Martín R; Rodríguez de Bethencourt Codes F; Bouraoui Y; Rodríguez Berriguete G; Oueslati R; Pérez-Utrilla M; De la Peña Barthel J; Paniagua Gómez-Alvarez R; Royuela García M
Arch Esp Urol; 2009 Jun; 62(5):359-66. PubMed ID: 19721171
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer.
Bouraoui Y; Ricote M; García-Tuñón I; Rodriguez-Berriguete G; Touffehi M; Rais NB; Fraile B; Paniagua R; Oueslati R; Royuela M
Cancer Detect Prev; 2008; 32(1):23-32. PubMed ID: 18400418
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profiling identifies an interaction of IL-6 and IL-1α to drive PSMA-PSA prostate clones.
Jemaa AB; Bouraoui Y; Rais NB; Nouira Y; Oueslati R
Immunobiology; 2016 Dec; 221(12):1424-1431. PubMed ID: 27451139
[TBL] [Abstract][Full Text] [Related]
4. Cytokine variations in patients with hormone treated prostate cancer.
Wise GJ; Marella VK; Talluri G; Shirazian D
J Urol; 2000 Sep; 164(3 Pt 1):722-5. PubMed ID: 10953133
[TBL] [Abstract][Full Text] [Related]
5. Profile of NF-κBp(65/NFκBp50) among prostate specific antigen sera levels in prostatic pathologies.
Bouraoui Y; Ben Jemaa A; Rodriguez G; Ben Rais N; Fraile B; Paniagua R; Sellemi S; Royuela M; Oueslati R
Pathol Biol (Paris); 2012 Oct; 60(5):301-5. PubMed ID: 21889270
[TBL] [Abstract][Full Text] [Related]
6. The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels.
Mechergui YB; Ben Jemaa A; Mezigh C; Fraile B; Ben Rais N; Paniagua R; Royuela M; Oueslati R
Inflammation; 2009 Jun; 32(3):202-10. PubMed ID: 19399601
[TBL] [Abstract][Full Text] [Related]
7. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345
[TBL] [Abstract][Full Text] [Related]
8. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
10. Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate.
Rodríguez-Berriguete G; Fraile B; de Bethencourt FR; Prieto-Folgado A; Bartolome N; Nuñez C; Prati B; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
BMC Cancer; 2010 Jan; 10():18. PubMed ID: 20078866
[TBL] [Abstract][Full Text] [Related]
11. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
14. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R
J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
[TBL] [Abstract][Full Text] [Related]
16. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
Björk T; Bjartell A; Abrahamsson PA; Hulkko S; di Sant'Agnese A; Lilja H
Urology; 1994 Apr; 43(4):427-34. PubMed ID: 7512295
[TBL] [Abstract][Full Text] [Related]
18. PSMA-PSA clones controlled by full Akt phosphorylation (T308+,S473+) recapitulate molecular features of human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R
Tunis Med; 2015; 93(8-9):556-64. PubMed ID: 26815524
[TBL] [Abstract][Full Text] [Related]
19. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer.
Drachenberg DE; Elgamal AA; Rowbotham R; Peterson M; Murphy GP
Prostate; 1999 Oct; 41(2):127-33. PubMed ID: 10477909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
